Calvin Sandra bought TVTX

November 4, 2025 · Form 4 insider transaction

Calvin Sandra bought 6,250 shares of Travere Therapeutics, Inc. at $8.93 per share, a transaction worth $55.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.